GSK plc (LON:GSK) Receives GBX 1,791.25 Consensus Price Target from Brokerages

GSK plc (LON:GSK – Get Free Report) has earned an average recommendation of “Moderate Buy” from the seven analysts that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have given a buy recommendation to the company. The […]

Leave a Reply

Your email address will not be published.

Previous post Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) EVP Sells $1,190,564.07 in Stock
Next post iRhythm Technologies, Inc. (NASDAQ:IRTC) Receives Consensus Recommendation of “Buy” from Analysts